Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients

Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Satoshi Murao 1 , Hideichi Makino 2 , Yukikazu Kaino 3 , Etsushi Konoue 4 , Jun Ohashi 5 , Kaichi Kida 3 , Yasuhisa Fujii 6 , Ikki Shimizu 6 , Eiji Kawasa...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 53; no. 10; pp. 2684 - 2690
Main Authors MURAO, Satoshi, MAKINO, Hideichi, KONDO, Shiori, TANAKA, Kiyonobu, TARUMI, Yoshinao, SETO, Isamu, KATO, Kenichi, OHNO, Keizo, KUSUNOKI, Yukiko, EBISUI, Osamu, TAKADA, Yasuharu, TANABE, Katsuya, KAINO, Yukikazu, TAKEMOTO, Koji, ONUMA, Hiroshi, NISHIMIYA, Tatsuya, OSAWA, Haruhiko, KONOUE, Etsushi, OHASHI, Jun, KIDA, Kaichi, FUJII, Yasuhisa, SHIMIZU, Ikki, KAWASAKI, Eiji, FUJIYAMA, Masao
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.10.2004
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Satoshi Murao 1 , Hideichi Makino 2 , Yukikazu Kaino 3 , Etsushi Konoue 4 , Jun Ohashi 5 , Kaichi Kida 3 , Yasuhisa Fujii 6 , Ikki Shimizu 6 , Eiji Kawasaki 7 , Masao Fujiyama 8 , Shiori Kondo 4 , Kiyonobu Tanaka 9 , Yoshinao Tarumi 10 , Isamu Seto 11 , Kenichi Kato 7 , Keizo Ohno 6 , Yukiko Kusunoki 6 , Osamu Ebisui 6 , Yasuharu Takada 9 , Katsuya Tanabe 12 , Koji Takemoto 3 , Hiroshi Onuma 2 , Tatsuya Nishimiya 2 and Haruhiko Osawa 2 1 Matsuyama Shimin Hospital, Ehime, Japan 2 Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan 3 Department of Pediatrics, Ehime University School of Medicine, Ehime, Japan 4 Matsuyama Red Cross Hospital, Ehime, Japan 5 Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan 6 Ehime Prefectural Central Hospital, Ehime, Japan 7 Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan 8 Fujiyama Clinic, Ehime, Japan 9 Saijo Central Hospital, Ehime, Japan 10 Minami Matsuyama Hospital, Ehime, Japan 11 BML, Tokyo, Japan 12 Ehime Rousai Hospital, Ehime, Japan Address correspondence and reprint requests to Dr. Hideichi Makino, Department of Laboratory Medicine, Ehime University School of Medicine, Shigenobu, Ehime 791-0295, Japan. E-mail: hidemak{at}m.ehime-u.ac.jp Abstract To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 ( DR4 ) and DRB1*0901-DQB1*0303 ( DR9 ), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9 : DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 ( DR8 ), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups ( P < 0.0001), but only DR9 had such an effect in the SO group ( P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes. APC, antigen-presenting cell LADA, latent autoimmune diabetes in adults RPE method, relative predispositional effects method Footnotes Accepted July 19, 2004. Received March 28, 2004. DIABETES
AbstractList Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Satoshi Murao 1 , Hideichi Makino 2 , Yukikazu Kaino 3 , Etsushi Konoue 4 , Jun Ohashi 5 , Kaichi Kida 3 , Yasuhisa Fujii 6 , Ikki Shimizu 6 , Eiji Kawasaki 7 , Masao Fujiyama 8 , Shiori Kondo 4 , Kiyonobu Tanaka 9 , Yoshinao Tarumi 10 , Isamu Seto 11 , Kenichi Kato 7 , Keizo Ohno 6 , Yukiko Kusunoki 6 , Osamu Ebisui 6 , Yasuharu Takada 9 , Katsuya Tanabe 12 , Koji Takemoto 3 , Hiroshi Onuma 2 , Tatsuya Nishimiya 2 and Haruhiko Osawa 2 1 Matsuyama Shimin Hospital, Ehime, Japan 2 Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan 3 Department of Pediatrics, Ehime University School of Medicine, Ehime, Japan 4 Matsuyama Red Cross Hospital, Ehime, Japan 5 Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan 6 Ehime Prefectural Central Hospital, Ehime, Japan 7 Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan 8 Fujiyama Clinic, Ehime, Japan 9 Saijo Central Hospital, Ehime, Japan 10 Minami Matsuyama Hospital, Ehime, Japan 11 BML, Tokyo, Japan 12 Ehime Rousai Hospital, Ehime, Japan Address correspondence and reprint requests to Dr. Hideichi Makino, Department of Laboratory Medicine, Ehime University School of Medicine, Shigenobu, Ehime 791-0295, Japan. E-mail: hidemak{at}m.ehime-u.ac.jp Abstract To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 ( DR4 ) and DRB1*0901-DQB1*0303 ( DR9 ), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9 : DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 ( DR8 ), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups ( P < 0.0001), but only DR9 had such an effect in the SO group ( P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes. APC, antigen-presenting cell LADA, latent autoimmune diabetes in adults RPE method, relative predispositional effects method Footnotes Accepted July 19, 2004. Received March 28, 2004. DIABETES
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1 DQB1 (DR4) and DRB1 *0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class Il haplotypes may be associated with the onset age of type 1 diabetes.
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes.
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P &lt; 0.0001), but only DR9 had such an effect in the SO group (P &lt; 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes.
Audience Professional
Author Etsushi Konoue
Koji Takemoto
Haruhiko Osawa
Yukikazu Kaino
Katsuya Tanabe
Jun Ohashi
Ikki Shimizu
Hideichi Makino
Hiroshi Onuma
Shiori Kondo
Eiji Kawasaki
Isamu Seto
Kenichi Kato
Kiyonobu Tanaka
Yukiko Kusunoki
Satoshi Murao
Osamu Ebisui
Tatsuya Nishimiya
Yasuhisa Fujii
Masao Fujiyama
Yoshinao Tarumi
Yasuharu Takada
Kaichi Kida
Keizo Ohno
Author_xml – sequence: 1
  givenname: Satoshi
  surname: MURAO
  fullname: MURAO, Satoshi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 2
  givenname: Hideichi
  surname: MAKINO
  fullname: MAKINO, Hideichi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 3
  givenname: Shiori
  surname: KONDO
  fullname: KONDO, Shiori
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 4
  givenname: Kiyonobu
  surname: TANAKA
  fullname: TANAKA, Kiyonobu
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 5
  givenname: Yoshinao
  surname: TARUMI
  fullname: TARUMI, Yoshinao
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 6
  givenname: Isamu
  surname: SETO
  fullname: SETO, Isamu
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 7
  givenname: Kenichi
  surname: KATO
  fullname: KATO, Kenichi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 8
  givenname: Keizo
  surname: OHNO
  fullname: OHNO, Keizo
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 9
  givenname: Yukiko
  surname: KUSUNOKI
  fullname: KUSUNOKI, Yukiko
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 10
  givenname: Osamu
  surname: EBISUI
  fullname: EBISUI, Osamu
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 11
  givenname: Yasuharu
  surname: TAKADA
  fullname: TAKADA, Yasuharu
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 12
  givenname: Katsuya
  surname: TANABE
  fullname: TANABE, Katsuya
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 13
  givenname: Yukikazu
  surname: KAINO
  fullname: KAINO, Yukikazu
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 14
  givenname: Koji
  surname: TAKEMOTO
  fullname: TAKEMOTO, Koji
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 15
  givenname: Hiroshi
  surname: ONUMA
  fullname: ONUMA, Hiroshi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 16
  givenname: Tatsuya
  surname: NISHIMIYA
  fullname: NISHIMIYA, Tatsuya
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 17
  givenname: Haruhiko
  surname: OSAWA
  fullname: OSAWA, Haruhiko
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 18
  givenname: Etsushi
  surname: KONOUE
  fullname: KONOUE, Etsushi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 19
  givenname: Jun
  surname: OHASHI
  fullname: OHASHI, Jun
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 20
  givenname: Kaichi
  surname: KIDA
  fullname: KIDA, Kaichi
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 21
  givenname: Yasuhisa
  surname: FUJII
  fullname: FUJII, Yasuhisa
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 22
  givenname: Ikki
  surname: SHIMIZU
  fullname: SHIMIZU, Ikki
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 23
  givenname: Eiji
  surname: KAWASAKI
  fullname: KAWASAKI, Eiji
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
– sequence: 24
  givenname: Masao
  surname: FUJIYAMA
  fullname: FUJIYAMA, Masao
  organization: BML, Tokyo, Ehime Rousai Hospital, Ehime, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16157334$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15448101$$D View this record in MEDLINE/PubMed
BookMark eNqFkm2r0zAUx4tc8T7oJxAkCAqCnTlNm7Yvx6Z3ymA-XMF3JU1Ot1y6pLdJ0X0Mv7Hp3WRMLsh5ETj8_ucp_8vozFiDUfQc6CRhLH-ntKjRo5tkbDLmeJE-ii6gZGXMkvzHWXRBKSQx5GV-Hl06d0sp5SGeROeQpWkBFC6i33PdNNijkeiINsRvkMys8b2uB6-tIbYhi-U0nn8lwigSz7-Qheha63ddEHhLvg1OYud1rVvtd2NmqobWx_f4bKNbtbFWxSvj0JOboCJA5ofJx4afRCcMOiSfhddovHsaPW5E6_DZ4b2Kvn94fzNbxMvV9cfZdBlLnhY-TmWJGecM0gSUKjJQRd1kFBohQbJS1WmhGK2FqFPVyDJhSQZZlpRCKkWLcMCr6PW-btfbuwGdr7Y6rNK2YRw7uIrzEsqcZ_8FoaApB8gD-PIf8NYOvQlLVAmEoTkUEKDJHlqLFittGut7IUMo3GoZfrjRIT-FhNGCpdlY9c2JIDAef_m1GJyriuvlKRs_xErbtrjGKtxvtjrl2Z6XvXWux6bqer0V_a4CWo0mq_6arMrYfS6YLKheHPYc6i2qo-bgqgC8OgDCSdE2vTBSuyPHIfRmY6G3e26j15ufusdju4f6_gEN_upE
CODEN DIAEAZ
CitedBy_id crossref_primary_10_2174_1871530323666221111153102
crossref_primary_10_3143_geriatrics_53_143
crossref_primary_10_1002_dmrr_571
crossref_primary_10_1111_j_1744_313X_2008_00749_x
crossref_primary_10_1155_2017_6924637
crossref_primary_10_1507_endocrj_KR_72
crossref_primary_10_3390_biology11111662
crossref_primary_10_1016_j_diabres_2005_12_007
crossref_primary_10_3389_fimmu_2022_952099
crossref_primary_10_2337_diacare_28_9_2330
crossref_primary_10_3143_geriatrics_48_565
crossref_primary_10_4103_ijem_IJEM_564_19
crossref_primary_10_1093_rheumatology_kes427
crossref_primary_10_1097_CCM_0b013e318183f608
crossref_primary_10_1007_s00125_009_1539_9
crossref_primary_10_4049_jimmunol_0802228
crossref_primary_10_1111_jdi_13091
crossref_primary_10_1507_endocrj_K09E_074
crossref_primary_10_2169_naika_95_1129
crossref_primary_10_2169_internalmedicine_52_0932
crossref_primary_10_1196_annals_1375_009
crossref_primary_10_1210_clinem_dgab589
crossref_primary_10_1210_clinem_dgad329
crossref_primary_10_1177_09612033221100156
crossref_primary_10_2337_dc09_1210
crossref_primary_10_1016_j_diabres_2007_08_031
crossref_primary_10_1155_2012_457546
crossref_primary_10_1016_j_humimm_2010_05_020
crossref_primary_10_1007_s13340_018_0362_2
crossref_primary_10_1111_j_1872_034X_2010_00753_x
crossref_primary_10_1590_S0004_27302006000300005
crossref_primary_10_3918_jsicm_22_273
crossref_primary_10_1002_dmrr_1148
crossref_primary_10_1210_jc_2012_2054
crossref_primary_10_1007_s10654_005_5081_x
crossref_primary_10_1016_j_jdiacomp_2024_108763
crossref_primary_10_1038_ncpendmet0351
crossref_primary_10_1297_cpe_17_113
crossref_primary_10_1007_s13340_021_00541_2
crossref_primary_10_1111_j_1464_5491_2012_03623_x
crossref_primary_10_1111_j_1399_0039_2007_00867_x
crossref_primary_10_1111_j_1399_0039_2007_00916_x
crossref_primary_10_1016_j_jaci_2020_01_011
crossref_primary_10_1111_j_1399_5448_2011_00833_x
crossref_primary_10_1196_annals_1337_006
crossref_primary_10_1016_j_diabres_2011_03_025
crossref_primary_10_1016_j_diabres_2008_01_024
crossref_primary_10_1007_s13340_024_00719_4
crossref_primary_10_1002_dmrr_3357
crossref_primary_10_1007_s13340_020_00448_4
crossref_primary_10_1016_j_jaut_2010_12_004
crossref_primary_10_1089_gtmb_2012_0221
crossref_primary_10_1111_j_2040_1124_2011_00139_x
crossref_primary_10_1177_0148607112462401
crossref_primary_10_14341_2072_0351_6080
crossref_primary_10_1155_2012_657156
crossref_primary_10_1021_pr300523x
crossref_primary_10_1186_1423_0127_20_12
Cites_doi 10.2337/diacare.8.2.114
10.1111/j.1464-5491.1994.tb00327.x
10.1007/BF00454876
10.1007/s001250051202
10.2337/diacare.26.8.2345
10.1111/j.1399-0039.1991.tb01854.x
10.1038/346574a0
10.2337/diacare.16.5.780
10.1038/371130a0
10.1111/j.1399-0039.1994.tb02375.x
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
10.1016/S0198-8859(00)00118-X
10.1046/j.1464-5491.2000.00205.x
10.1111/j.1464-5491.1994.tb00275.x
10.1016/S0198-8859(01)00301-9
10.1016/S0168-8227(03)00147-5
10.1056/NEJM200002033420501
10.1093/hmg/10.19.2025
10.1056/NEJM198904063201401
10.1016/0198-8859(94)00075-2
10.1016/S0198-8859(97)00186-9
10.2337/diacare.20.4.524
10.1006/jaut.1996.0089
10.1006/jaut.1999.0315
10.1056/NEJM199006283222602
10.1016/S0168-8227(85)80006-1
10.2337/diacare.20.7.1183
10.2337/diabetes.51.2.545
10.1172/JCI116110
10.1007/BF02342437
10.2337/diacare.25.12.2302
10.3109/08830189809054404
10.2337/diabetes.46.11.1893
10.2337/diacare.25.6.995
10.1016/S0140-6736(01)05415-0
10.1111/j.1399-0039.1996.tb02512.x
10.1007/BF00265401
10.2337/diab.41.3.378
10.2337/diabetes.48.1.150
10.1172/JCI14257
ContentType Journal Article
Copyright 2004 INIST-CNRS
COPYRIGHT 2004 American Diabetes Association
COPYRIGHT 2004 American Diabetes Association
Copyright American Diabetes Association Oct 2004
Copyright_xml – notice: 2004 INIST-CNRS
– notice: COPYRIGHT 2004 American Diabetes Association
– notice: COPYRIGHT 2004 American Diabetes Association
– notice: Copyright American Diabetes Association Oct 2004
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
Q9U
S0X
7T5
H94
7X8
DOI 10.2337/diabetes.53.10.2684
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: High School
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
ProQuest Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Consumer Health Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library (ProQuest Database)
Science Journals (ProQuest Database)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE - Academic

MEDLINE
Research Library Prep
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 2690
ExternalDocumentID 709783141
A123083457
10_2337_diabetes_53_10_2684
15448101
16157334
diabetes_53_10_2684
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
53G
55
5GY
5RE
5RS
5VS
7RV
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ABUWG
ACDCL
ACGOD
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AFFNX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EX3
F5P
FRP
FYUFA
GICCO
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
J5H
K-O
K9-
KM
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5
M7P
MBDVC
O0-
O9-
OB3
OBH
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
WH7
WOQ
WOW
X7M
XZ
ZA5
ZGI
ZXP
ZY1
---
.55
.GJ
.XZ
08P
0R~
18M
1CY
354
6PF
AAKAS
AAUGY
AAYOK
ACGFO
ADZCM
AEGXH
AERZD
AFHIN
AI.
AIAGR
BTFSW
CCPQU
EMOBN
HZ~
H~9
IQODW
ITC
K2M
M5~
MVM
N4W
NAPCQ
O5R
O5S
OHH
TEORI
TR2
UKHRP
VH1
VVN
W8F
XOL
YFH
YHG
YOC
YQJ
~KM
AIZAD
ALIPV
CGR
CUY
CVF
ECM
EIF
HMCUK
NPM
AAYXX
CITATION
7XB
8FK
K9.
Q9U
7T5
H94
7X8
ID FETCH-LOGICAL-c648t-4c9e56631421dd851d8bf501fac1c39db48d30baab4dfc9232515529acdd08233
IEDL.DBID 8C1
ISSN 0012-1797
IngestDate Fri Oct 25 05:00:35 EDT 2024
Fri Aug 16 22:12:48 EDT 2024
Thu Oct 10 19:59:14 EDT 2024
Wed Nov 13 00:09:23 EST 2024
Thu Aug 01 20:09:28 EDT 2024
Thu Aug 22 20:39:03 EDT 2024
Fri Aug 23 02:43:58 EDT 2024
Sat Sep 28 08:38:36 EDT 2024
Sun Oct 22 16:06:43 EDT 2023
Fri Jan 15 19:45:55 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Endocrinopathy
Human
HLA-System
Sensitivity
Type 1 diabetes
Haplotype
Japanese
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c648t-4c9e56631421dd851d8bf501fac1c39db48d30baab4dfc9232515529acdd08233
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://diabetesjournals.org/diabetes/article-pdf/53/10/2684/373631/zdb01004002684.pdf
PMID 15448101
PQID 216486181
PQPubID 34443
PageCount 7
ParticipantIDs proquest_journals_216486181
proquest_miscellaneous_66919765
gale_infotracacademiconefile_A123083457
gale_incontextgauss_8GL_A123083457
highwire_diabetes_diabetes_53_10_2684
gale_incontextcollege_GICCO_A123083457
pubmed_primary_15448101
proquest_miscellaneous_18046117
pascalfrancis_primary_16157334
crossref_primary_10_2337_diabetes_53_10_2684
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 2004-10-01
PublicationDateYYYYMMDD 2004-10-01
PublicationDate_xml – month: 10
  year: 2004
  text: 2004-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2004
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References 2022031207303499100_R41
2022031207303499100_R20
2022031207303499100_R42
2022031207303499100_R40
2022031207303499100_R1
2022031207303499100_R23
2022031207303499100_R2
2022031207303499100_R24
2022031207303499100_R3
2022031207303499100_R21
2022031207303499100_R4
2022031207303499100_R22
2022031207303499100_R5
2022031207303499100_R6
2022031207303499100_R7
2022031207303499100_R8
2022031207303499100_R9
2022031207303499100_R16
2022031207303499100_R38
2022031207303499100_R17
2022031207303499100_R39
2022031207303499100_R14
2022031207303499100_R36
2022031207303499100_R15
2022031207303499100_R37
2022031207303499100_R18
2022031207303499100_R19
2022031207303499100_R30
2022031207303499100_R31
2022031207303499100_R12
2022031207303499100_R34
2022031207303499100_R13
2022031207303499100_R35
2022031207303499100_R10
2022031207303499100_R32
2022031207303499100_R11
2022031207303499100_R33
2022031207303499100_R27
2022031207303499100_R28
2022031207303499100_R25
2022031207303499100_R26
2022031207303499100_R29
References_xml – ident: 2022031207303499100_R3
  doi: 10.2337/diacare.8.2.114
– ident: 2022031207303499100_R10
– ident: 2022031207303499100_R4
  doi: 10.1111/j.1464-5491.1994.tb00327.x
– ident: 2022031207303499100_R38
  doi: 10.1007/BF00454876
– ident: 2022031207303499100_R32
  doi: 10.1007/s001250051202
– ident: 2022031207303499100_R34
  doi: 10.2337/diacare.26.8.2345
– ident: 2022031207303499100_R37
  doi: 10.1111/j.1399-0039.1991.tb01854.x
– ident: 2022031207303499100_R40
  doi: 10.1038/346574a0
– ident: 2022031207303499100_R6
  doi: 10.2337/diacare.16.5.780
– ident: 2022031207303499100_R8
  doi: 10.1038/371130a0
– ident: 2022031207303499100_R33
– ident: 2022031207303499100_R12
  doi: 10.1111/j.1399-0039.1994.tb02375.x
– ident: 2022031207303499100_R25
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– ident: 2022031207303499100_R41
  doi: 10.1016/S0198-8859(00)00118-X
– ident: 2022031207303499100_R28
  doi: 10.1046/j.1464-5491.2000.00205.x
– ident: 2022031207303499100_R7
  doi: 10.1111/j.1464-5491.1994.tb00275.x
– ident: 2022031207303499100_R9
  doi: 10.1016/S0198-8859(01)00301-9
– ident: 2022031207303499100_R23
  doi: 10.1016/S0168-8227(03)00147-5
– ident: 2022031207303499100_R5
  doi: 10.1056/NEJM200002033420501
– ident: 2022031207303499100_R11
  doi: 10.1093/hmg/10.19.2025
– ident: 2022031207303499100_R16
  doi: 10.1056/NEJM198904063201401
– ident: 2022031207303499100_R18
  doi: 10.1016/0198-8859(94)00075-2
– ident: 2022031207303499100_R19
  doi: 10.1016/S0198-8859(97)00186-9
– ident: 2022031207303499100_R20
  doi: 10.2337/diacare.20.4.524
– ident: 2022031207303499100_R30
  doi: 10.1006/jaut.1996.0089
– ident: 2022031207303499100_R31
  doi: 10.1006/jaut.1999.0315
– ident: 2022031207303499100_R35
  doi: 10.1056/NEJM199006283222602
– ident: 2022031207303499100_R29
  doi: 10.1016/S0168-8227(85)80006-1
– ident: 2022031207303499100_R24
  doi: 10.2337/diacare.20.7.1183
– ident: 2022031207303499100_R15
  doi: 10.2337/diabetes.51.2.545
– ident: 2022031207303499100_R17
  doi: 10.1172/JCI116110
– ident: 2022031207303499100_R13
  doi: 10.1007/BF02342437
– ident: 2022031207303499100_R22
  doi: 10.2337/diacare.25.12.2302
– ident: 2022031207303499100_R39
  doi: 10.3109/08830189809054404
– ident: 2022031207303499100_R42
  doi: 10.2337/diabetes.46.11.1893
– ident: 2022031207303499100_R26
  doi: 10.2337/diacare.25.6.995
– ident: 2022031207303499100_R2
  doi: 10.1016/S0140-6736(01)05415-0
– ident: 2022031207303499100_R14
  doi: 10.1111/j.1399-0039.1996.tb02512.x
– ident: 2022031207303499100_R27
  doi: 10.1007/BF00265401
– ident: 2022031207303499100_R36
  doi: 10.2337/diab.41.3.378
– ident: 2022031207303499100_R21
  doi: 10.2337/diabetes.48.1.150
– ident: 2022031207303499100_R1
  doi: 10.1172/JCI14257
SSID ssj0006060
Score 2.1193974
Snippet Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Satoshi Murao...
To clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared...
SourceID proquest
gale
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 2684
SubjectTerms Adult
Age of Onset
Biological and medical sciences
Care and treatment
Child
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 1 - genetics
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Gene Frequency
Genetic Predisposition to Disease - genetics
Haplotypes
HLA-DQ Antigens - genetics
HLA-DR Antigens - genetics
Humans
Japan - epidemiology
Medical sciences
Type 1 diabetes
Title Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients
URI http://diabetes.diabetesjournals.org/content/53/10/2684.abstract
https://www.ncbi.nlm.nih.gov/pubmed/15448101
https://www.proquest.com/docview/216486181
https://search.proquest.com/docview/18046117
https://search.proquest.com/docview/66919765
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZoKyEuiHdDYbEQjwtu17GTOCe07Lasqr4oVNqb5TyMKlXJUmcP_Az-MTOJs6tIlGt2JHsz45nP9pdvCHkHNS6ymTFMqsIyacOEpVIJWHgK8EFaGttKCp2exfMrebyIFp6b4zytss-JbaIu6hzPyA9CwPUqhnr0efmLYdMovFz1HTS2yA6HMoeMPjXdMDwAm3dfoPAQVTiTTnQoFCI56A829yOxj89iJQeFqU_PvWYwUiaNg7dmu3YXd-PRti4dPSIPPaCkky4CHpN7ZfWE3D_1V-ZPyZ-Zb4ECCYFeVxQAH0VJqr7RFa0tnZ9M2OySmqqgbPaNzs3ypsazWUebmn5fuZb60rJof-OTCWp2sNZ8rYzMzitXNhS3tZRTz7NpBzyGcoxtLulFJ-HqnpGro8Mf0znzfRhYDu-8YTJPS0B9gsuQFwVAtEJlNhpza3Kei7TIwM9iDA7PZGFzQIwh9o0JU5MXBV7kiedku6qrcpdQxPJGRcaCoUy5MePcyFJmAGqEkmkWkE-9E_Syk9vQsE1Bn-neZzoS7TPwWUA-oKM0CllUyJTJu9MWDdOfnusJlGWAmDJKAvJ2aPjTrJzT6uvJwOijN7J1c2ty479QgKmjSNbA8n0fGZtp_XN-o0HYbP4TAMlECDDY6-NI--Th9DrUA_Jm_SuserzKAYfVK6e5QqF8ntxtEccpB6gZBeRFF56bsSPYkkMmfvnfsffIg07TEnmLr8h2c7sqXwP-arIR2UoWyahdayOy8-Xw7OLyLxBsL6c
link.rule.ids 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SYUWgvxuOB2HTuJc0KrXUoouy2PVurNcpwYIaFkabIHfgb_mJnE2VUkytUZyY5nPPPZHn9DyEuIcZHLjWFSFY5JFyYslUrAwlOAD9LSuI5SaHkSZ-fy-CK68Lk5jU-rHHxi56iL2uIZ-WEIuF7FEI_erX4xLBqFl6u-gsZ1cgOiforrUs22GR6AzfsXKDxEFs6kJx0KhUgOh4PNg0gcYFus5CgwDe554AzGlEnTwKy5vtzF1Xi0i0tHd8kdDyjptLeAe-RaWd0nN5f-yvwB-TP3JVDAIdAfFQXAR5GSaih0RWtHs8WUzb9SUxWUzb_QzKx-1ng229C2pt_WTZf60mXR_saWKXJ2sE58w4zMTqumbCluaymnPs-m6_AYwjGWuaSfewrX5iE5P3p_NsuYr8PALMx5y6RNS0B9gsuQFwVAtELlLppwZyy3Ii1y0LOYgMJzWTgLiDHEujFhamxR4EWeeER2qroqnxCKWN6oyDgQlCk3ZmKNLGUOoEYomeYBeTsoQa96ug0N2xTUmR50piPRtYHOAvIaFaWRyKLCTBnbn7ZoGP7sVE8hLAPElFESkBdjwe9m3TRafViMhN54IVe3l8Ya_0IBho4kWSPJV4NlbIf1z_Htjcxm-08AJBMhQGB3sCPtnUejN6YekP3NV1j1eJUDCqvXjeYKifJ5crVEHKccoGYUkMe9eW77jmBLDp746X_73ie3srPlQi8-nnzaJbd7fkvMYXxGdtrLdfkcsFib73Ur7i_pdzAZ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkyZeEN9kg81CfLzgtYmdxHlCZV0po-vKYNLeLOfDaBJKypw-8GfwH3OXOK0iMV6dk-zkznc_-y6_I-Q1xLjQpFozIXPDhAlilgjJYeNJwAdJoU1DKXS2iGaX4vQqvHKUQtaVVXY-sXHUeZXhHfkwAFwvI4hHQ-OqIpaT6YfVL4YNpDDR6rpp3CU7sYj4aEB2Pp4slhcbtwxIvf0fxQ-QkzNuKYgCzuNhd815FPIjHIuk6IWpzll3DMJYQKktfEPTNr-4HZ02UWr6gNx38JKOW3t4SO4U5SOye-YS6I_Jn4lriALugV6XFOAfRYKqru0VrQydzcdsckF1mVM2-UpnevWzwptaS-uKflvbphCmqan9jSNjZPBgjfiGJ5mdl7aoKR5yqU9d1U0z4SkEZ2x6SZctoat9Qi6nJ9-PZ8x1ZWAZaKBmIksKwIDcF4Gf5wDYcpmacOQbnfkZT_IUtM5HoP5U5CYD_BhgF5kg0VmeY1qPPyWDsiqL54Qistcy1AYEReJrPcq0KEQKEIdLkaQeed8pQa1a8g0FhxbUmep0pkLejIHOPPIWFaWQ1qJEC8nauxcFyz8-V2MI0gA4RRh75FVf8IdeW6vkp3lP6J0TMlV9ozPt_leApSNlVk_yTWcZ22X9c30HPbPZvhPAyphzENjv7Eg5V2LVxvA9crh5Cj4AEzugsGptlS-RNt-Pb5eIosQH4Bl65Flrntu5Qzigg1_e--_ch2QXtpuaf1582Sf3WrJLLGh8QQb1zbp4CcCsTg_clvsL0Rg14g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+the+Contribution+of+HLA-DR+and+-DQ+Haplotypes+to+Susceptibility+to+Adult-+and+Childhood-Onset+Type+1+Diabetes+in+Japanese+Patients&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Murao%2C+Satoshi&rft.au=Makino%2C+Hideichi&rft.au=Kaino%2C+Yukikazu&rft.au=Konoue%2C+Etsushi&rft.date=2004-10-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=53&rft.issue=10&rft.spage=2684&rft_id=info:doi/10.2337%2Fdiabetes.53.10.2684&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=709783141
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon